DMC Biotechnologies, Inc. - Renewable Carbon News

Renewable Carbon News
DMC Biotechnologies, Inc.

3 July 20242 July 2024

Precision Fermentation: What is it?

How Precision Fermentation can accelerate the journey to Net Zero by 2040

24 June 202418 June 2024

Danone, DMC, Michelin and Crédit Agricole Centre France join forces to create a cutting-edge biotechnology platform

With an investment of over 16 million euro, the Center for Sustainable Materials in Clermont-Ferrand within the Parc Cataroux will become an innovation accelerator, supported by Michelin

16 November 202313 November 2023

DMC opens new lab in Research Triangle Park, NC – New 9,500 Square Foot R&D Facility

The facility is home to DMC’s workflows in strain and metabolic engineering, high throughput testing, as well as bench and pilot scale fermentation

3 April 202330 March 2023

The 50 Hottest Companies in the Bioeconomy 2023

The Digest slideshow of the top 50 bioeconomy companies

2 November 202231 October 2022

An interview with Kelly Smith, VP R&D DMC Biotech

“The crises, while tragic, created an opportunity to rethink security of supply in terms of where things are manufactured, and DMC is positioned to lead the change.” Kelly Smith, VP R&D at DMC Biotech talks with Il Bioeconomista

14 February 202211 February 2022

DMC: Subsequent Close of Series B Financing, Total Raised $39 million

DMC is commercial with its first bio-based chemical intermediate with primary applications in sustainable detergents and human nutrition

Start-up für biobasierte Chemikalien gewinnt weitere strategische Investoren

Nachträglicher Abschluss der Serie-B-Finanzierung mit einem Gesamtbetrag von 39 Millionen Dollar

9 December 20216 December 2021

DMC Biotechnologies has completed the first close of its Series B fundraising, raising $34 million (USD)

Company has a deep pipeline of predictable, scalable, cost-competitive products, addressing sustainability challenges across a wide range of industries

28 May 202116 June 2021

DMC’s Downstream Processing Proven At Scale

The purification of L-alanine from the fermentation broth was successfully completed for more than 6,000 kg of product

4 May 202118 June 2021

DMC and Conagen Partner for Commercial Manufacturing of L-alanine

Partnership combines Conagen’s production expertise with DMC's bioprocess technology and follows DMC’s demonstration of commercial-scale production in March 2021

21 April 202118 June 2021

DMC & SCG Execute Agreement for DMC’s Amino Acid Product Line in ASEAN

"We are excited by the opportunity to bring these biobased, sustainable solutions to the region and to contribute to a more sustainable society"

6 April 202118 June 2021

DMC CTO & Co-Founder Mike Lynch Publishes Technoeconomic Analysis (TEA) Calculator to Take the Guesswork Out of Bioprocess Development

The Bioprocess Technoeconomic Analysis (TEA) tool will help users – academics, startups, funding agencies, R&D team, and investors – make commercially relevant decisions about technology development and deployment

19 March 202117 March 2021

DMC Demonstrates Full Commercial Scale at Record Speed

The commercial performance metrics were demonstrated, meaning that no further strain improvements are required to achieve the target selling price

17 March 202115 March 2021

Celebrating women CEOs in the renewable chemicals market

Here is a list of women CEOs blazing trails in the (renewable) chemicals market

9 December 20207 December 2020

The 10 Most Innovative Bioeconomy CEOs in 2020. Now choose the number 1

Now you can choose the most innovative CEO responding to the Il Bioeconomista survey

3 December 20202 December 2020

An interview with Matt Lipscomb, CEO DMC Bio

Exclusive interview with Matt Lipscomb, CEO of DMC Bio, the US company which is producing bio-based chemicals using fermentation

12 February 20209 February 2020

DMC Biotech Completes Successful Pilot of L-alanine

The predictability of the DMC process has been demonstrated from high through put screening to commercially relevant scale

6 June 20193 June 2019